Breaking News Instant updates and real-time market news.

2020-02-26 17:21:27 VAC Marriott Vacations $96.00 / -5.78 (-5.68%) 17:21 02/26/20 02/26 17:21 02/26/20 17:21	Marriott Vacations CEO says 'ILG integration continues to go well' "I am very pleased with how we ended the year, growing contract sales by 10% in the fourth quarter and Adjusted EBITDA by 15%, once again illustrating the strength and resilience of our business model. We grew VPG by 9% in the fourth quarter, including 12% growth at our Legacy-ILG sales centers, as we continue to narrow the gap with Legacy-MVW," said Stephen Weisz, president and CEO. "The ILG integration continues to go well and we expect to achieve at least $95 million of run-rate synergies by the end of 2020, well on our way towards achieving at least $125 million in run-rate savings by the end of 2021. As a result, 2020 is shaping up to be another great year for Marriott Vacations Worldwide, with estimated contract sales growth of 7% to 11% and Adjusted EBITDA growth of 8% to 13%."	27 Feb 10 Mar 11 Mar
VAC Marriott Vacations $96.00 / -5.78 (-5.68%) 12/09/19 Truist The 21 smaller cap stocks SunTrust sees rallying over 20% in 2020 11/14/19 Jefferies Marriott Vacations shares can keep working, says Jefferies 11/06/19 Truist Marriott Vacations price target raised to $155 from $147 at SunTrust 08/20/19 JPMorgan Marriott Vacations upgraded to Overweight at JPMorgan

2020-02-26 17:21:27

VAC

Marriott Vacations

$96.00 / -5.78 (-5.68%)

17:21

02/26/20

02/26

17:21

02/26/20

17:21

Marriott Vacations CEO says 'ILG integration continues to go well'

"I am very pleased with how we ended the year, growing contract sales by 10% in the fourth quarter and Adjusted EBITDA by 15%, once again illustrating the strength and resilience of our business model. We grew VPG by 9% in the fourth quarter, including 12% growth at our Legacy-ILG sales centers, as we continue to narrow the gap with Legacy-MVW," said Stephen Weisz, president and CEO. "The ILG integration continues to go well and we expect to achieve at least $95 million of run-rate synergies by the end of 2020, well on our way towards achieving at least $125 million in run-rate savings by the end of 2021. As a result, 2020 is shaping up to be another great year for Marriott Vacations Worldwide, with estimated contract sales growth of 7% to 11% and Adjusted EBITDA growth of 8% to 13%."

27
Feb
10
Mar
11
Mar

VAC Marriott Vacations

$96.00 / -5.78 (-5.68%)

12/09/19 Truist: The 21 smaller cap stocks SunTrust sees rallying over 20% in 2020

11/14/19 Jefferies: Marriott Vacations shares can keep working, says Jefferies

11/06/19 Truist: Marriott Vacations price target raised to $155 from $147 at SunTrust

08/20/19 JPMorgan: Marriott Vacations upgraded to Overweight at JPMorgan

TODAY'S FREE FLY STORIES

Upgrade	Exxon Mobil upgraded to Hold from Sell at DZ Bank » 05:22 03/05/21 03/05 05:22 03/05/21 05:22 XOM Exxon Mobil $58.74 / +2.22 (+3.93%) DZ Bank analyst Werner… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options XOM Exxon Mobil $58.74 / +2.22 (+3.93%) 03/03/21 Exxon Mobil must change direction, not just appoint board candidates, CURE says 03/03/21 Exxon Mobil sees FY21 capital spending $16B-$19B 03/01/21 Michael Angelakis and Jeffrey Ubben join ExxonMobil board 02/24/21 Exxon Mobil to sell U.K. upstream central and northern North Sea assets XOM Exxon Mobil $58.74 / +2.22 (+3.93%) 03/04/21 MKM Partners Exxon Mobil price target raised to $60 from $56 at MKM Partners 03/04/21 Morgan Stanley Exxon Mobil price target raised to $60 from $57 at Morgan Stanley 03/04/21 Truist Exxon Mobil price target raised to $60 from $50 at Truist 03/04/21 Citi Exxon Mobil price target raised to $53 from $44 at Citi XOM Exxon Mobil $58.74 / +2.22 (+3.93%) 02/02/21 Exxon Mobil reports Q4 ex-items EPS 3c, consensus 1c 02/01/21 Notable companies reporting before tomorrow's open 02/01/21 Notable companies reporting before tomorrow's open 12/30/20 Exxon Mobil says Q4 income boosted by up to $600M from gas prices XOM Exxon Mobil $58.74 / +2.22 (+3.93%) 03/04/21 Exxon sues Macquarie to avoid paying $11.7M for missed deliveries, Reuters says 03/04/21 OPEC+ agrees to maintain oil output levels, Bloomberg reports 03/02/21 Exxon CEO says economics, policies creating carbon capture market, Reuters says 03/01/21 Ubben, Angelakis to join board of Exxon Mobil, CNBC reports XOM Exxon Mobil $58.74 / +2.22 (+3.93%) 03/01/21 Fly Intel: Wall Street's top stories for Monday 03/01/21 Fly Intel: Wall Street's top stories at midday 03/01/21 Fly Intel: Pre-market Movers 02/02/21 Fly Intel: Wall Street's top stories for Tuesday XOM Exxon Mobil $58.74 / +2.22 (+3.93%) 03/03/21 Exxon Mobil call volume above normal and directionally bullish 03/01/21 Unusually active option classes on open March 1st 02/09/21 Unusually active option classes on open February 9th 02/08/21 Exxon Mobil call volume above normal and directionally bullish
Hot Stocks	Dada Nexus, Unilever announce livestreaming e-commerce event partnership » 05:22 03/05/21 03/05 05:22 03/05/21 05:22 DADA Dada Nexus $32.13 / -2.77 (-7.94%) , UL Unilever $53.52 / +0.11 (+0.21%) Dada Group (DADA) and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options DADA UL DADA Dada Nexus $32.13 / -2.77 (-7.94%) 01/29/21 Dada appoints Rui Yu to board of directors 01/27/21 Dada Group, Ferrero enter pact to create on-demand retail model for snacks 01/25/21 Dada Nexus works with retailers to provide delivery service in Shijiazhuang 01/15/21 Dada Nexus announces JD Daojia partners with over 20 regional supermarkets UL Unilever $53.52 / +0.11 (+0.21%) 12/21/20 Dada Nexus, Unilever announce new strategic partnership 12/18/20 Unilever to end advertising pause on Facebook, Twitter in U.S. in January 11/30/20 Unilever completes unification of group legal structure 11/25/20 Unilever to acquire SmartyPants Vitamins, terms not disclosed DADA UL DADA Dada Nexus $32.13 / -2.77 (-7.94%) 01/18/21 CICC Dada Nexus initiated with an Outperform at CICC 01/07/21 KeyBanc Dada Nexus initiated with an Overweight at KeyBanc 12/08/20 Fly Intel: Top five analyst downgrades 12/08/20 Morgan Stanley Dada Nexus downgraded to Equal Weight on competition risk at Morgan Stanley UL Unilever $53.52 / +0.11 (+0.21%) 02/08/21 Barclays Unilever price target lowered to EUR 48 from EUR 55 at Barclays 12/08/20 Investec Unilever upgraded to Buy from Hold at Investec 12/03/20 Societe Generale Unilever initiated with a Buy at Societe Generale 11/25/20 Jefferies Jefferies sees 'strong buying opportunity' upcoming after Unilever unification DADA DADA Dada Nexus $32.13 / -2.77 (-7.94%) 11/19/20 Dada Nexus sees Q4 revenue RMB2B-RMB2.1B 11/19/20 Dada Nexus reports Q3 adjusted EPS RMB0.36 vs RMB1.71 last year 03 Dec 05 Jun UL UL Unilever $53.52 / +0.11 (+0.21%) 01/20/21 Unilever says its suppliers must pay staff 'living wage,' BBC says 01/13/21 Unilever CEO encourages employees to get COVID vaccine, Reuters says 11/30/20 Unilever testing out four-day work week in New Zealand, Reuters says 11/17/20 Unilever targets EUR1B in sales from plant-based products by 2027, FT reports DADA DADA Dada Nexus $32.13 / -2.77 (-7.94%) 11/30/20 Fly Intel: After-Hours Movers 03/08/21 Dada Nexus - DADA DADA DADA Dada Nexus $32.13 / -2.77 (-7.94%) 12/23/20 new option listings and one option delisting on December 23rd
Downgrade	Wipro downgraded to Sell from Reduce at ICICI Securities » 05:22 03/05/21 03/05 05:22 03/05/21 05:22 WIT Wipro $6.44 / -0.02 (-0.31%) ICICI Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings WIT Wipro $6.44 / -0.02 (-0.31%) 03/04/21 Wipro to acquire Capco 02/15/21 Wipro announces five-year strategic partnership with Telefonica Germany 01/15/21 Wipro chosen by Fiat Chrysler to establish first global digital hub in India 01/13/21 Wipro sees Q4 IT Services revenue up 1.5%-3.5% sequentially to $2.1B-$2.14B WIT Wipro $6.44 / -0.02 (-0.31%) 12/21/20 Goldman Sachs Wipro resumed with a Sell at Goldman Sachs 10/14/20 Investec Wipro downgraded to Hold from Buy at Investec 10/06/20 ICICI Securities Wipro downgraded to Hold from Buy at ICICI Securities 07/16/20 Wedbush Infosys upgraded to Outperform on improving visibility at Wedbush WIT Wipro $6.44 / -0.02 (-0.31%) 01/13/21 Wipro reports Q3 EPS 7c, two estimates 6c 10/13/20 Wipro sees Q3 IT Services revenue up 1.5%-3.5% sequentially to $2.02B-$2.06B 10/13/20 Wipro reports Q2 EPS 6c, two estimates 6c
Upgrade	Energias de Portugal upgraded to Buy from Hold at Societe Generale » 05:21 03/05/21 03/05 05:21 03/05/21 05:21 EDPFY Energias de Portugal $0.00 / + (+0.00%) Societe Generale analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research EDPFY Energias de Portugal $0.00 / + (+0.00%) 01/20/21 Morgan Stanley Energias de Portugal resumed with an Overweight at Morgan Stanley 09/21/20 RBC Capital Energias de Portugal upgraded to Sector Perform at RBC Capital 09/16/20 Credit Suisse Energias de Portugal price target raised to EUR 5 at Credit Suisse 08/28/20 JPMorgan Energias de Portugal price target raised to EUR 4.65 from EUR 4.50 at JPMorgan
Downgrade	Roche downgraded to Hold from Buy at Erste Group » 05:20 03/05/21 03/05 05:20 03/05/21 05:20 RHHBY Roche $0.00 / + (+0.00%) Erste Group analyst Hans… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events RHHBY Roche $0.00 / + (+0.00%) 03/04/21 Genentech's Acterma approved by FDA for regulating pulmonary function in SSc-ILD 03/04/21 Dicerna, Roche begin combo trial of GalXC for chronic HBV treatment 03/03/21 Adaptive says Genentech suspends development of shared antigen target candidate 02/26/21 Regeneron announces CHMP recommendation for COVID-19 antibody cocktail RHHBY Roche $0.00 / + (+0.00%) 03/03/21 Goldman Sachs Adaptive Biotechnologies downgraded to Neutral from Buy at Goldman Sachs 02/25/21 Berenberg Roche price target lowered to CHF 320 from CHF 325 at Berenberg 02/24/21 Morgan Stanley Roche price target lowered to CHF 345 from CHF 365 at Morgan Stanley 02/23/21 BofA BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list RHHBY Roche $0.00 / + (+0.00%) 02/04/21 Roche reports 2020 core EPS CHF 19.16 vs. CHF 20.16 last year 10/27/20 Oncolytics announces new GI cancer study using 10/15/20 Roche confirms outlook for 2020 based on assessment of COVID-19 10/15/20 Roche reports 9 months group sales CHF43.98B vs. CHF46.07B last year RHHBY Roche $0.00 / + (+0.00%) 02/11/21 Roche arthritis drug reduced Covid deaths in study, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports RHHBY Roche $0.00 / + (+0.00%) 12/26/20 Week in review: How Trump's policies moved stocks 11/30/20 Fly Intel: Wall Street's top stories for Monday 11/30/20 Fly Intel: Wall Street's top stories at midday 11/21/20 Week in review: How Trump's policies moved stocks 03/25/21 Roche - RHHBY

Upgrade	Amadeus IT Group upgraded to Buy from Hold at Erste Group » 05:20 03/05/21 03/05 05:20 03/05/21 05:20 AMADY Amadeus IT Group $0.00 / + (+0.00%) Erste Group analyst Hans… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research AMADY Amadeus IT Group $0.00 / + (+0.00%) 02/26/21 Microsoft, Amadeus IT Group announce strategic partnership AMADY Amadeus IT Group $0.00 / + (+0.00%) 03/02/21 UBS Amadeus IT Group price target lowered to EUR 61 from EUR 65 at UBS 03/01/21 JPMorgan Amadeus IT Group price target raised to EUR 58 from EUR 50 at JPMorgan 03/01/21 Oddo BHF Amadeus IT Group upgraded to Neutral from Reduce at Oddo BHF 03/01/21 Oddo BHF Amadeus IT Group upgraded to Neutral from Reduce at Oddo BHF
Initiation	Cadeler initiated with a Buy at Kepler Cheuvreux » 05:19 03/05/21 03/05 05:19 03/05/21 05:19 CADLF Cadeler $0.00 / + (+0.00%) Kepler Cheuvreux… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CADLF Cadeler $0.00 / + (+0.00%) 01/06/21 DNB Markets Cadeler initiated with a Buy at DNB Markets
Earnings	GSX Techedu reports Q4 EPS (39c), consensus (38c) » 05:19 03/05/21 03/05 05:19 03/05/21 05:19 GSX GSX Techedu $84.11 / -2.9 (-3.33%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GSX GSX Techedu $84.11 / -2.9 (-3.33%) 03/03/21 GSX Techedu falls -13.3% 01/13/21 GSX Techedu rises 27.1% 12/07/20 GSX Techedu rises 15.3% 11/23/20 GSX 'as close as possible' to being proven fraud before delisting, Block says GSX GSX Techedu $84.11 / -2.9 (-3.33%) 02/01/21 JPMorgan GSX Techedu downgraded to Underweight from Neutral at JPMorgan 01/29/21 GSX Techedu downgraded to Sell from Neutral at China Merchants 01/28/21 Goldman Sachs GSX Techedu downgraded to Sell from Neutral at Goldman Sachs 12/17/20 Fly Intel: Top five analyst downgrades GSX GSX Techedu $84.11 / -2.9 (-3.33%) 11/20/20 GSX Techedu reports Q3 EPS (57c), consensus (31c) GSX GSX Techedu $84.11 / -2.9 (-3.33%) 12/18/20 Seven whistleblowers have described 'fraud' at GSX Techedu, Aurelius Value says 10/12/20 WSJ article on GSX 'somewhat misses the point,' Muddy Waters says 10/12/20 GSX proves to be one of the year's worst short bets, WSJ says GSX GSX Techedu $84.11 / -2.9 (-3.33%) 02/01/21 Fly Intel: Pre-market Movers 01/28/21 Fly Intel: Wall Street's top stories for Thursday 01/28/21 Fly Intel: Wall Street's top stories at midday 11/20/20 Fly Intel: Wall Street's top stories for Friday 08:00 Today GSX Techedu - GSX GSX GSX Techedu $84.11 / -2.9 (-3.33%) 03/04/21 GSX Techedu put volume heavy and directionally bearish 03/03/21 GSX Techedu put volume heavy and directionally bearish 01/21/21 GSX Techedu call volume above normal and directionally bullish 12/28/20 GSX Techedu put volume heavy and directionally bearish
Upgrade	AXA upgraded to Conviction Buy from Buy at Bryan Garnier » 05:19 03/05/21 03/05 05:19 03/05/21 05:19 AXAHY AXA $0.00 / + (+0.00%) Bryan Garnier analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals AXAHY AXA $0.00 / + (+0.00%) 03/03/21 Deutsche Bank AXA price target raised to EUR 25 from EUR 24.50 at Deutsche Bank 03/02/21 Morgan Stanley AXA price target lowered to EUR 24 from EUR 24.20 at Morgan Stanley 03/01/21 Berenberg AXA price target raised to EUR 23.30 from EUR 21.50 at Berenberg 02/26/21 RBC Capital AXA price target raised to EUR 24 from EUR 23 at RBC Capital AXAHY AXA $0.00 / + (+0.00%) 02/24/21 Baker Hughes, AXA, 16 others wind down work on Nord Stream 2, Reuters says 09/24/20 Allianz and Athora in talks for joint bid for Aviva's French unit, Reuters says
Upgrade	Meggitt upgraded to Outperform from Neutral at Exane BNP Paribas » 05:18 03/05/21 03/05 05:18 03/05/21 05:18 MEGGF Meggitt $0.00 / + (+0.00%) Exane BNP Paribas analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research MEGGF Meggitt $0.00 / + (+0.00%) 02/11/21 Morgan Stanley Meggitt price target lowered to 455 GBp from 465 GBp at Morgan Stanley 02/04/21 Jefferies Meggitt price target raised to 500 GBp from 375 GBp at Jefferies 01/08/21 JPMorgan Meggitt price target lowered to 390 GBp from 395 GBp at JPMorgan 12/15/20 Panmure Gordon Meggitt downgraded to Sell from Hold at Panmure Gordon

Upgrade	Woodside Petroleum upgraded to Overweight from Neutral at JPMorgan » 05:17 03/05/21 03/05 05:17 03/05/21 05:17 WOPEY Woodside Petroleum $0.00 / + (+0.00%) JPMorgan analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research WOPEY Woodside Petroleum $0.00 / + (+0.00%) 12/09/20 JPMorgan Woodside Petroleum downgraded to Neutral from Overweight at JPMorgan 07/17/20 Citi Woodside Petroleum downgraded to Neutral from Buy at Citi 06/25/20 JPMorgan Woodside Petroleum upgraded to Overweight from Neutral at JPMorgan 05/05/20 Bernstein Woodside Petroleum upgraded to Outperform from Market Perform at Bernstein
Downgrade	Brembo downgraded to Reduce from Hold at Kepler Cheuvreux » 05:16 03/05/21 03/05 05:16 03/05/21 05:16 BRBOF Brembo $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BRBOF Brembo $0.00 / + (+0.00%) 02/01/21 Exane BNP Paribas Brembo downgraded to Underperform from Neutral at Exane BNP Paribas
Upgrade	Belimo Holding upgraded to Hold from Reduce at Kepler Cheuvreux » 05:15 03/05/21 03/05 05:15 03/05/21 05:15 BLHWF Belimo Holding $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research BLHWF Belimo Holding $0.00 / + (+0.00%) 12/11/20 Berenberg Belimo Holding price target raised to CHF 8,250 from CHF 8,000 at Berenberg 05/26/20 UBS Belimo Holding price target lowered to CHF 5,150 from CHF 5,200 at UBS 03/18/20 Berenberg Belimo Holding upgraded to Buy from Hold at Berenberg
Earnings	ObsEva reports Q4 EPS (32c), consensus (42c) » 05:15 03/05/21 03/05 05:15 03/05/21 05:15 OBSV ObsEva $3.37 / -0.32 (-8.67%) As of December 31, 2020,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options OBSV ObsEva $3.37 / -0.32 (-8.67%) 01/11/21 ObsEva provides updates on Yselty program 01/04/21 ObsEva appoints David Renas as CFO 12/10/20 ObsEva announces Yselty met primary endpoint in PRIMROSE 1, PRIMROSE 2 studies 11/24/20 ObsEva submits MAA to EMA for Yselty OBSV ObsEva $3.37 / -0.32 (-8.67%) 01/04/21 H.C. Wainwright ObsEva price target lowered to $17 from $23 at H.C. Wainwright 11/09/20 JPMorgan ObsEva downgraded to Underweight from Neutral at JPMorgan 10/05/20 H.C. Wainwright ObsEva price target lowered to $23 from $36 at H.C. Wainwright 07/07/20 Wedbush Selloff in ObsEva shares 'overdone,' says Wedbush OBSV ObsEva $3.37 / -0.32 (-8.67%) 11/05/20 ObsEva reports Q3 EPS (49c), consensus (34c) 30 Oct OBSV ObsEva $3.37 / -0.32 (-8.67%) 12/10/20 Fly Intel: Pre-market Movers OBSV ObsEva $3.37 / -0.32 (-8.67%) 02/16/21 Largest borrow rate increases among liquid names 01/27/21 Largest borrow rate increases among liquid names 01/22/21 Largest borrow rate increases among liquid names
Initiation	Technip Energies initiated with a Buy at Kepler Cheuvreux » 05:15 03/05/21 03/05 05:15 03/05/21 05:15 THNPF Technip Energies $0.00 / + (+0.00%) Kepler Cheuvreux… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research THNPF Technip Energies $0.00 / + (+0.00%) 03/01/21 Exane BNP Paribas Technip Energies initiated with a Neutral at Exane BNP Paribas 03/01/21 Morgan Stanley Technip Energies initiated with an Overweight at Morgan Stanley 02/22/21 Barclays Technip Energies initiated with an Equal Weight at Barclays

Upgrade	Barclays upgraded to Add from Sell at AlphaValue » 05:14 03/05/21 03/05 05:14 03/05/21 05:14 BCS Barclays $9.21 / -0.235 (-2.49%) AlphaValue upgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BCS Barclays $9.21 / -0.235 (-2.49%) 02/18/21 Barclays committed to medium-term targets, including RoTE of over 10% over time 02/18/21 Barclays sees 'meaningful' y/y RoTe improvement in 2021 02/18/21 Barclays declares 1.0p 2020 full year dividend 01/04/21 Penn National CFO David Williams steps down, Felicia Hendrix to succeed BCS Barclays $9.21 / -0.235 (-2.49%) 02/23/21 JPMorgan Barclays price target raised to 190 GBp from 180 GBp at JPMorgan 02/22/21 RBC Capital Barclays price target raised to 150 GBp from 140 GBp at RBC Capital 02/19/21 Deutsche Bank Barclays price target raised to 200 GBp from 180 GBp at Deutsche Bank 01/28/21 Berenberg Barclays price target raised to 180 GBp from 160 GBp at Berenberg BCS Barclays $9.21 / -0.235 (-2.49%) 02/18/21 Barclays reports Q4 group profit before tax GBP0.6B vs. GBP1.1B last year 10/23/20 Barclays reports Q3 group profit before tax GBP 1.1B vs. GBP 0.2B last year 10/13/20 Fly Intel: What to watch in next round of big banks' earnings reports BCS Barclays $9.21 / -0.235 (-2.49%) 03/02/21 French bankers want new EU law to move euro clearing to Frankfurt, Reuters says 02/18/21 Barclays CEO sees staff returning to office this year, Bloomberg reports 12/16/20 Barclays mulls raising bonus pool for traders by roughly 10%, Bloomberg says 10/01/20 Goldman Sachs to buy GM credit-card business for about $2.5B, WSJ reports BCS Barclays $9.21 / -0.235 (-2.49%) 10/23/20 Fly Intel: Wall Street's top stories for Friday 10/23/20 Fly Intel: Wall Street's top stories at midday 10/01/20 Fly Intel: Wall Street's top stories for Thursday 09/11/20 The Intersection: Crypto and Wall Street This Week 03/25/21 REITwise 2021 Virtual Conference BCS Barclays $9.21 / -0.235 (-2.49%) 12/16/20 Barclays call volume above normal and directionally bullish 12/14/20 Unusual call flow in option market yesterday 12/11/20 Short-term premium buyer in Barclays 12/11/20 Unusually active option classes on open December 11th
Upgrade	Henkel upgraded to Hold from Sell at Nord/LB » 05:13 03/05/21 03/05 05:13 03/05/21 05:13 HENKY Henkel $0.00 / + (+0.00%) Nord/LB analyst Thorsten… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Events HENKY Henkel $0.00 / + (+0.00%) 01/12/21 UBS Henkel price target raised to EUR 81 from EUR 80 at UBS 01/05/21 Barclays Barclays trims Henkel Adhesive estimates on slower recovery expectations 12/03/20 JPMorgan Henkel upgraded to Overweight from Neutral at JPMorgan 11/30/20 Commerzbank Henkel upgraded to Buy from Hold at Commerzbank 03/10/21 Global Consumer & Retail Virtual Conference 2021
Hot Stocks	Moderna announces Takeda NDA submission to distribute COVID-19 vaccine in Japan » 05:12 03/05/21 03/05 05:12 03/05/21 05:12 MRNA Moderna $132.21 / +1.01 (+0.77%) , TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) Moderna (MRNA) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 03/04/21 Moderna, IBM to collaborate on COVID vaccine supply, distribution data sharing 03/04/21 GC Pharma to support Moderna distribution of 40M doses of COVID-19 Vaccine 02/25/21 Moderna's chief medical officer Tal Zaks to leave company in late September 02/24/21 Moderna makes new capital investment to boost manufacturing capacity TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 03/03/21 Takeda secures rights to soticlestat from Ovid Therapeutics for $196M upfront 02/26/21 Novavax, Takeda finalize license agreement for COVID-19 vaccine in Japan 02/26/21 Takeda to divest type 2 diabetes portfolio to Teijin Pharma for JPY 133B 02/24/21 Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 03/01/21 Chardan Moderna price target raised to $182 from $107 at Chardan 02/26/21 Barclays Moderna price target raised to $178 from $169 at Barclays 02/26/21 Brookline Moderna price target raised to $205 from $180 at Brookline 02/25/21 Piper Sandler Moderna transitioning into profitable company, says Piper Sandler TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 03/03/21 RBC Capital Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal 01/29/21 Morgan Stanley Morgan Stanley downgrades Jazz to Equal Weight ahead of competitor readout 12/29/20 Needham Needham names Phathom Pharmaceuticals Top Pick for 2021 12/15/20 Needham Phathom Pharmaceuticals price target raised to $55 from $45 at Needham MRNA MRNA Moderna $132.21 / +1.01 (+0.77%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) 19 May MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 03/03/21 Some Catholic bishops advise against certain Covid-19 vaccines, WSJ reports 02/28/21 AstraZeneca sells stake in Moderna for over $1B, The Times reports 02/17/21 Moderna to supply EU with another 150M vaccine doses in 2021, FT reports 02/12/21 FDA tells Moderna it can boost vaccine supply in each vial, NY Times reports TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 10/09/20 Takeda, others testing convalescent plasma treatment in Covid, WSJ reports MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 02/25/21 Fly Intel: Pre-market Movers 02/24/21 Fly Intel: After-Hours Movers 02/12/21 Fly Intel: Wall Street's top stories for Friday 02/12/21 Fly Intel: Wall Street's top stories at midday TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 03/03/21 Fly Intel: Wall Street's top stories at midday 03/03/21 Fly Intel: Pre-market Movers 03/16/21 31st Annual Healthcare Virtual Conference MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 03/01/21 Moderna call volume above normal and directionally bullish 02/01/21 Moderna call volume above normal and directionally bullish 01/25/21 Moderna call volume above normal and directionally bullish 12/17/20 Moderna call volume above normal and directionally bullish TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 01/22/21 Takeda Pharmaceutical call volume above normal and directionally bullish
Recommendations	Costco price target lowered to $395 from $410 at Baird » 05:07 03/05/21 03/05 05:07 03/05/21 05:07 COST Costco $319.35 / -4.53 (-1.40%) Baird analyst Peter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options COST Costco $319.35 / -4.53 (-1.40%) 02/03/21 Costco reports January SSS rose 15.9% 01/06/21 Costco December SSS, ex impact from gas, FX rose 10.9% 01/06/21 Costco December E-commerce sales ex gas, FX up 61.6% 11/24/20 Tinley Beverage Company completes full production at Long Beach facility COST Costco $319.35 / -4.53 (-1.40%) 02/03/21 Baird Costco January core comps re-accelerated, says Baird 02/02/21 Cleveland Research Costco U.S. sales slightly improved in January, says Cleveland Research 01/07/21 Deutsche Bank Costco price target raised to $347 from $344 at Deutsche Bank 01/06/21 Baird Costco saw some deceleration in December core comp sales, says Baird COST Costco $319.35 / -4.53 (-1.40%) 03/04/21 Costco reports Q2 EPS $2,14, consensus $2.44 03/04/21 Notable companies reporting after market close 12/10/20 Costco reports Q1 total company comparable sales up 15.4% 12/10/20 Costco reports Q1 EPS $2.62, consensus $2.05 COST Costco $319.35 / -4.53 (-1.40%) 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports 12/15/20 FedEx, UPS limiting packages they pick up, creating backlogs, WSJ reports COST Costco $319.35 / -4.53 (-1.40%) 03/04/21 Fly Intel: After-Hours Movers 03/01/21 Fly Intel: What to watch in Target's earnings report 02/26/21 Fly Intel: Wall Street's top stories at midday 12/10/20 Fly Intel: After-Hours Movers COST Costco $319.35 / -4.53 (-1.40%) 12/10/20 Costco options imply 3.8% move in share price post-earnings 11/17/20 Early notable gainers among liquid option names on November 17th 09/24/20 Costco options imply 6.0% move in share price post-earnings 09/24/20 Unusually active option classes on open September 24th
Hot Stocks	Daqo signs three-year, 52,700 MT polysilicon supply agreement with Shangji » 05:07 03/05/21 03/05 05:07 03/05/21 05:07 DQ Daqo New Energy $85.93 / -8.76 (-9.25%) Daqo New Energy announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Events Options DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 03/02/21 Daqo New Energy enters three-year polysilicon supply agreement with Zhonghuan 02/02/21 Daqo New Energy provides update on potential IPO in China 01/13/21 Daqo New Energy falls -6.4% 01/04/21 Daqo New Energy rises 16.1% DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 03/02/21 Roth Capital Daqo New Energy price target raised to $115 from $105 at Roth Capital 02/08/21 Roth Capital Bill could be 'meaningful positive' for solar stocks, says Roth Capital 01/26/21 Roth Capital Daqo New Energy price target raised to $100 from $40 at Roth Capital 12/21/20 Roth Capital ITC/PTC extensions likely included in COVID relief package, says Roth Capital DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 01/08/21 JinkoSolar, Daqo named in report on companies tied to forced labor use, NYT says DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 02/13/21 Charged: Tesla discloses $1.5B bitcoin investment 01/09/21 Charged: Apple self-driving EV said to be years away 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/26/20 Week in review: How Trump's policies moved stocks 03/09/21 Daqo New Energy - DQ DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 02/25/21 Daqo New Energy call volume above normal and directionally bullish 01/11/21 Daqo New Energy put volume heavy and directionally bearish

Recommendations	Fulgent Genetics price target raised to $140 from $135 at Piper Sandler » 05:06 03/05/21 03/05 05:06 03/05/21 05:06 FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 02/16/21 Fulgent Genetics, BioIQ partner on COVID-19 testing programs 12/29/20 Fulgent Genetics extends partnership with NTC DOE and Health 12/17/20 PRA Health partners with Fulgent Genetics to enhance COVID-19 monitoring program 11/18/20 Fulgent Genetics, LANES, LA DHS partner on COVID-19 testing FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 02/03/21 Piper Sandler Fulgent Genetics price target raised to $135 from $100 at Piper Sandler 02/01/21 Oppenheimer Fulgent Genetics price target raised to $130 from $75 at Oppenheimer 02/01/21 Oppenheimer Invitae downgraded to Perform on valuation at Oppenheimer 01/08/21 Credit Suisse Fulgent Genetics downgraded to Underperform from Neutral at Credit Suisse FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 03/04/21 Fulgent Genetics sees FY21 EPS $12.50, consensus $11.55 03/04/21 Fulgent Genetics reports Q4 EPS $6.20, consensus $4.05 11/23/20 Fulgent Genetics raises 2020 revenue view to at least $300M from $235M 11/09/20 Fulgent Genetics reports Q3 EPS$2.08 , consensus 55c FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 09/09/20 Report says U.S. may need 193M coronavirus tests per month, STAT reports FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 11/09/20 Pfizer, BioNTech lift market as COVID vaccine shows effectiveness 09/22/20 Fly Intel: Wall Street's top stories for Tuesday 03/16/21 31st Annual Healthcare Virtual Conference
Recommendations	Alphatec price target raised to $19 from $17 at Piper Sandler » 05:05 03/05/21 03/05 05:05 03/05/21 05:05 ATEC Alphatec $15.86 / -0.69 (-4.17%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events ATEC Alphatec $15.86 / -0.69 (-4.17%) 02/01/21 Alphatec relocates to new headquarters in Carlsbad 12/17/20 Alphatec to acquire EOS imaging for $79.7M in cash, sees accretion ATEC Alphatec $15.86 / -0.69 (-4.17%) 01/29/21 Piper Sandler Alphatec price target raised to $17 from $12 at Piper Sandler 01/12/21 Piper Sandler Piper remains buyer of Alphatec despite Covid pressures 12/21/20 H.C. Wainwright Alphatec price target raised to $16 from $12 at H.C. Wainwright 12/18/20 Lake Street Alphatec price target raised to $20 from $15 at Lake Street ATEC Alphatec $15.86 / -0.69 (-4.17%) 03/04/21 Alphatec reports Q4 EPS (35c), consensus (21c) 01/12/21 Alphatec sees 2021 revenue approximately $178M, consensus $183.08M 01/12/21 Alphatec sees 2020 revenue $144.8M-$145.1M, consensus $144.13M 01/12/21 Alphatec sees Q4 revenue $43.8M-$44.1M, consensus $43.66M 14 Oct ATEC Alphatec $15.86 / -0.69 (-4.17%) 03/04/21 Fly Intel: After-Hours Movers 10/19/20 Fly Intel: After-Hours Movers 10/13/20 Fly Intel: After-Hours Movers 10/08/20 Fly Intel: Wall Street's top stories for Thursday 03/08/21 Alphatec
Upgrade	Bombardier upgraded to Outperform from Market Perform at BMO Capital » 05:04 03/05/21 03/05 05:04 03/05/21 05:04 BDRBF Bombardier $0.00 / + (+0.00%) BMO Capital analyst Fadi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BDRBF Bombardier $0.00 / + (+0.00%) 03/04/21 Bombardier targets 2025 total revenues about $7.5B 03/04/21 Bombardier expects business jet deliveries to begin gradual recovery in 2021 03/03/21 Bombardier, Aston Martin sign LOI for custom design services on business jets 02/23/21 Bombardier reports suffering 'limited cybersecurity breach' BDRBF Bombardier $0.00 / + (+0.00%) 02/16/21 Cowen Bombardier downgraded to Underperform from Market Perform at Cowen 02/16/21 Scotiabank Bombardier price target raised to C$0.65 from C$0.55 at Scotiabank 02/12/21 National Bank Bombardier price target lowered to C$0.70 from C$0.80 at National Bank 02/12/21 BMO Capital Bombardier price target raised to C$0.85 from C$0.40 at BMO Capital BDRBF Bombardier $0.00 / + (+0.00%) 02/11/21 Bombardier reports Q4 cont ops EPS (1c), consensus 0c 02/11/21 Bombardier sees FY21 adjusted EBITDA greater than $500M BDRBF Bombardier $0.00 / + (+0.00%) 11/13/20 Disney upgrade among today's top calls on Wall Street 05/06/21 Bombardier - BDRBF
Recommendations	Cutera price target raised to $42 from $38 at Piper Sandler » 05:02 03/05/21 03/05 05:02 03/05/21 05:02 CUTR Cutera $26.21 / -8.715 (-24.96%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events CUTR Cutera $26.21 / -8.715 (-24.96%) 02/17/21 Cutera not providing formal guidance at this time CUTR Cutera $26.21 / -8.715 (-24.96%) 02/18/21 Piper Sandler Cutera price target raised to $38 from $28 at Piper Sandler 11/05/20 Piper Sandler Cutera price target raised to $28 from $22 at Piper Sandler 09/14/20 Stephens Cutera price target raised to $24 from $18 at Stephens 08/07/20 Piper Sandler Cutera should be bought at these 'depressed levels,' says Piper Sandler CUTR Cutera $26.21 / -8.715 (-24.96%) 02/17/21 Cutera reports Q4 EPS 12c, consensus 4c 11/04/20 Cutera reports Q3 EPS (13c), consensus (33c) 17 Apr CUTR Cutera $26.21 / -8.715 (-24.96%) 11/04/20 Fly Intel: After-Hours Movers 03/18/21 Cutera
Upgrade	Fifth Third upgraded to Conviction Buy from Buy at Goldman Sachs » 05:00 03/05/21 03/05 05:00 03/05/21 05:00 FITB Fifth Third $35.57 / -0.36 (-1.00%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events FITB Fifth Third $35.57 / -0.36 (-1.00%) 02/22/21 Fifth Third CEO Carmichael sells over 155,000 common shares 01/21/21 Fifth Third sees y/y adjusted positive operating leverage in 2H21 01/21/21 Fifth Third sees utilization to remain unchanged for 1H, up 1% in 2H 01/21/21 Fifth Third doesn't see growing investment portfolio in near-term FITB Fifth Third $35.57 / -0.36 (-1.00%) 02/17/21 Citi Citi recommends two new U.S. bank pair trades 01/27/21 Argus Fifth Third price target raised to $35 from $27 at Argus 01/22/21 Wedbush Fifth Third price target raised to $39 from $36 at Wedbush 01/22/21 RBC Capital Fifth Third price target raised to $32 from $27 at RBC Capital FITB Fifth Third $35.57 / -0.36 (-1.00%) 01/21/21 Fifth Third reports Q4 EPS 78c, consensus 69c 10/22/20 Fifth Third reports Q3 EPS 78c, consensus 60c 10/21/20 Notable companies reporting before tomorrow's open 10/21/20 Notable companies reporting before tomorrow's open FITB Fifth Third $35.57 / -0.36 (-1.00%) 01/20/21 Notable companies reporting before tomorrow's open 01/20/21 Notable companies reporting before tomorrow's open 11/21/20 Citizens Financial, Truist among regional bank stocks to grab, Barron's says FITB Fifth Third $35.57 / -0.36 (-1.00%) 09/25/20 Cruise Line upgrades among today's top calls on Wall Street 04/20/21 Fifth Third - FITB 04/13/21 Fifth Third Bancorp

Events

Earnings calls, analyst events, roadshows and more

CLLS
Today at 08:00

Cellectis - CLLS Conference Calls
EGLE
Today at 08:00

Eagle Bulk Shipping - EGLE Conference Calls
GSX
Today at 08:00

GSX Techedu - GSX Conference Calls
BIG
Today at 08:00

Big Lots - BIG Conference Calls
COE
Today at 08:00

China Online Education - COE Conference Calls
IVA
Today at 08:00

Inventiva - IVA Conference Calls
Today at 08:00

European Capital Goods Industry Meetings
Today at 08:30

Employment Situation--Average Hourly Earnings M/M: February 2021 Government Event
Today at 08:30

Employment Situation: Non-Farm Payrolls M/M: February 2021 Government Event
Today at 08:30

Employment Situation--Average Hourly Earnings Y/Y: February 2021 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC Priced at: $28.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLRX X SLRX Salarius Pharmaceuticals Secondary Managers: Ladenburg Priced at: $1.3685 14.615M Shares VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James Priced at: $34.00 2.206M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR Priced at: $11.50 4.35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham Priced at: $31.00 4.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SUI X SUI Sun Communities Secondary Managers: Citi, BofA, BMO Capital, JPMorgan & RBC Capital Priced at: $140.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan $46.50 3.9M Shares FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan $73.25 4.65M Shares
Thurs	AMRC X AMRC Ameresco Spot Secondary Managers: BofA & Oppenheimer, Baird, Canaccord, Guggenheim, William Blair $44.00-46.25 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Marriott Vacations CEO says 'ILG integration continues to go well'

TODAY'S FREE FLY STORIES

Get Full Fly Access